|
gptkbp:instance_of
|
gptkb:pharmaceuticals
|
|
gptkbp:academic_programs
|
gptkb:Ms._Sarah_J._Smith
|
|
gptkbp:acquisition
|
gptkb:Taris_Biomedical
gptkb:Actelion
|
|
gptkbp:advertising
|
gptkb:Dr._Jennifer_Taubert
gptkb:Mr._Michael_D._Duffy
gptkb:Mr._Robert_T._Jones
|
|
gptkbp:awards
|
various industry awards
|
|
gptkbp:clinical_trial
|
ongoing
Phase 3 trials
Phase 1 trials
Phase 2 trials
|
|
gptkbp:conducts_research_on
|
gptkb:Dr._Mathai_Mammen
|
|
gptkbp:founded
|
1953
|
|
gptkbp:founder
|
gptkb:Paul_Janssen
|
|
gptkbp:global_presence
|
over 150 countries
|
|
gptkbp:has_authority_over
|
Ms. Laura K. Green
|
|
gptkbp:head
|
Mr. Thomas H. White
|
|
gptkbp:head_of_state
|
gptkb:Ms._Emily_R._Brown
gptkb:Dr._John_D._Mc_Carthy
|
|
gptkbp:headquarters
|
gptkb:Beerse,_Belgium
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Janssen Pharmaceuticals
|
|
gptkbp:industry
|
gptkb:pharmaceuticals
|
|
gptkbp:number_of_employees
|
over 40,000
|
|
gptkbp:parent_company
|
gptkb:Johnson_&_Johnson
|
|
gptkbp:partnerships
|
government agencies
biotechnology companies
various academic institutions
|
|
gptkbp:products
|
antibiotics
antipsychotics
oncology drugs
immunology drugs
|
|
gptkbp:public_relations
|
gptkb:Ms._Angela_M._Lee
|
|
gptkbp:regulatory_compliance
|
gptkb:Ms._Jennifer_L._Mc_Carthy
|
|
gptkbp:research_areas
|
gptkb:diabetes
psychiatry
infectious diseases
pain management
pulmonary hypertension
|
|
gptkbp:research_focus
|
oncology
neuroscience
cardiovascular diseases
infectious diseases
|
|
gptkbp:supply_chain
|
gptkb:Mr._David_A._Johnson
|
|
gptkbp:sustainability_initiatives
|
gptkb:healthcare_access
community engagement
environmental responsibility
|
|
gptkbp:website
|
www.janssen.com
|
|
gptkbp:bfsParent
|
gptkb:Johnson_&_Johnson
gptkb:Astra_Zeneca
gptkb:Gilead_Sciences
|
|
gptkbp:bfsLayer
|
4
|